Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/10/2019
SIETES contiene 92826 citas

 
 
 1 a 20 de 25 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Cummings SR, Lui LY, Eastell R, Allen IE. Association between drug treatments for patients with osteoporosis and overall mortality rates: a meta-analysis. JAMA Intern Med 2019:19 de agosto. [Ref.ID 103179]
3.Tiene citas relacionadas
Eastell R, Walsh JS. Is it time to combine osteoporosis therapies?. Lancet 2013;382:5-7. [Ref.ID 95783]
4. Cita con resumen
Abrahamsen B, Eiken P, Eastell R. Proton pump inhibitor use and the antifracture efficacy of alendronate. Arch Intern Med 2011;171:998-1003. [Ref.ID 91309]
5.Tiene citas relacionadas Cita con resumen
Jamal SA, Hamilton CJ, Eastell R, Cummings SR. Effect of nitroglycerin ointment on bone density and strength in postmenopausal women. A randomized trial. JAMA 2011;305:800-7. [Ref.ID 90244]
6.Tiene citas relacionadas
Cummings SR, Thompson J, Eastell R. Lasofoxifene for postmenopausal women with osteoporosis. The authors reply. N Engl J Med 2010;362:2228-9. [Ref.ID 88664]
7.Tiene citas relacionadas Cita con resumen
Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, Cauley J, Leung PC, Boonen S, Santora A, de Papp A, Bauer DC, for the Fracture Intervention Trial and HORIZON Pivotal Fracture Trial Steering Committees. Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur. N Engl J Med 2010;362:1761-71. [Ref.ID 88372]
8.Tiene citas relacionadas Cita con resumen
Cummings SR, Ensrud K, Delmas PD, LaCroix AZ, Vukicevic S, Reid DM, Goldstein S, Sriram U, Lee A, Thompson J, Armstrong RA, Thompson DD, Powles T, Zanchetta J, Kendler D, Neven P, Eastell R, for the PEARL Study Investigators. Lasofoxifene in postmenopausal women with osteoporosis. N Engl J Med 2010;362:686-96. [Ref.ID 87912]
9.Tiene citas relacionadas Cita con resumen
Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C, FREEDOM Trial. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 2009;361:756-65. [Ref.ID 86411]
10.Tiene citas relacionadas Cita con resumen
Abrahamsen B, Eiken P, Eastell R. More on reports of esophageal cancer with oral phisphosphonate use. N Engl J Med 2009;360:1789. [Ref.ID 85675]
11.Tiene citas relacionadas
Wardlaw D, Cummings SR, Van Meirhaeghe J, Bastian L, Tillman JB, Ranstam J, Eastell R, Shabe P, Talmadge K, Boonen S. Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet 2009;373:1016-24. [Ref.ID 85508]
12.Tiene citas relacionadas Cita con resumen
Cummings SR, Ettinger B, Delmas PD, Kenemans P, Stathopoulos V, Verweij P, Mol-Arts M, Kloosterboer L, Mosca L, Christiansen C, Bilezikian J, Kerzberg EM, Johnson S, Zanchetta J, Grobbee DE, Seifert W, Eastell R, for the LIFT Trial Investigators. The effects of tibolone in older postmenopausal women. N Engl J Med 2008;359:697-708. [Ref.ID 83749]
13.Tiene citas relacionadas Cita con resumen
Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR, for the HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007;356:1809-22. [Ref.ID 79934]
14. Cita con resumen
Reid I R, Eastell R, Fogelman I, Adachi JD, Rosen A, Netelenbos C, Watts NB, Seeman E, Ciaccia AV, Draper MW. A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women. Arch Intern Med 2004;164:871-9. [Ref.ID 69941]
15. Cita con resumen
McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier P-J, Reginster J-Y, for the Hip Intervention Program Study Group. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344:333-40. [Ref.ID 55110]
16.
Clark PJ, Eastell R, Barker ME. Zinc supplementation and bone growth in pubertal girls. Lancet 1999;354:485. [Ref.ID 46380]
17.Tiene citas relacionadas
Eastell R. Commentary: Bone density can be used to assess fracture risk. BMJ 1999;318:864-5. [Ref.ID 44037]
18.Tiene citas relacionadas
Eastell R, Cadogan J, Bright N, Barker ME. Milk intake and bone mineral acquisition in adolescent girls. Authors' reply. BMJ 1998;316:1747-8. [Ref.ID 40022]
19.Tiene citas relacionadas
Eastell R. Treatment of postmenopausal osteoporosis. Dr. Eastell replies. N Engl J Med 1998;339:203. [Ref.ID 39188]
20.
Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med 1998;338:736-46. [Ref.ID 37259]
Seleccionar todas
 
 1 a 20 de 25 siguiente >>